Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 841 results for "novartis ag"

Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

(Reuters) - An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG. Reuters, 18 hours ago

Novartis hands over TB drugs

10:06 ET | About: Novartis AG (NVS) Novartis (NVS -0.2%) signs a licensing agreement with the Global Alliance for TB Drug Development for its experimental tuberculosis drugs that have been discovered at the Novartis Institutes for Tropical ...
 Seeking Alpha1 day ago Novartis, Global Alliance Collaborate To Search For TB Cure  Bidness Etc1 day ago Reports on Neurochemistry from Novartis Institute for Biomedical Research Provide New Insights [The protein interacting with C-kinase (PICK1)...  4 Traders1 day ago Novartis AG, Global Alliance For TB Drug Development Link Up To Search For TB Cure  BioSpace1 day ago

Novartis Pharma to invest $35 million in Gamida Cell

Novartis Pharma AG, a Switzerland-based subsidiary of Novartis AG, has signed an investment agreement to invest $35 million for a 15% equity stake in Gamida Cell, Ltd., an Israel-based developer of stem cell therapies. Novartis is a ...
 Individual.com1 day ago Novartis to invest $35 mn in Gamida Cell, an Israeli developer of stem cell therapies  PharmaBiz1 day ago NOVARTIS : Trademark Application for "DON'T LET HEADACHES STEAL YOUR DREAMS" Filed by Novartis  4 Traders1 day ago NOVARTIS' : Trademark Application for "VAGISTAT" Filed  4 Traders1 day ago

Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk

Research and Markets ( has announced the addition of the "Global Hormone Replacement Therapy Market 2014-2018" report to their offering. Hormone replacement therapy, also known as ...
 Individual.com1 day ago Research and Markets: Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk  Morningstar.com1 day ago RESEARCH AND MARKETS : Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk  4 Traders1 day ago Global Macular Edema Market 2014-2018 with Bayer AG, F. Hoffmann-La Roche, Novartis & Regeneron Pharmaceuticals Dominating  Individual.com1 week ago

Ranbaxy gets FDA nod for Novartis generic pill

Ranbaxy Laboratories Ltd has received approval from the US Food and Drug Administration to launch a cheaper copy of Novartis AG's blood pressure pill Diovan, bolstering its outlook after a raft of regulatory bans for poor production quality at its India ...
 Times of India1 month ago Ranbaxy gets FDA approval for Novartis's Diovan generic  Reuters1 month ago India's Ranbaxy gets FDA approval for Novartis's Diovan generic  Reuters1 month ago

Ranbaxy up; nod to generic version of Novartis drug

Ranbaxy Laboratories rose 5.8 percent in early trading after the U.S. Food and Drug Administration said on Thursday it had approved the company's generic version of Novartis AG's blood pressure drug Diovan. Investors say current market size of Diovan in the ...
 Sify1 month ago India's Ranbaxy gains; U.S. drug regulator approves generic version of Novartis drug  Reuters1 month ago Ranbaxy jumps after winning USFDA approval for generic  India Infoline1 month ago Ranbaxy jumps on buzz USFDA OKs generic drug  Business Standard1 month ago

Sandoz launches topical therapy for erectile dysfunction in Sweden

Sandoz Sweden, a generic pharmaceuticals division of Novartis AG, has launched Vitaros, a new topical therapy for erectile dysfunction, or ED in Sweden. "This launch demonstrates Sandoz's commitment to finding novel and innovative ways to meet ...
 Individual.com14 hours ago Apricus Biosciences Announces the Launch of Its Topical Treatment for Erectile Dysfunction Vitaros(R) in Germany by Hexal  Town Hall3 days ago Apricus Biosciences announces launch of topical treatment for erectile dysfunction vitaros in Germany by Hexal  Pharmaceutical Business Review2 days ago

Novartis to Invest $35M in Gamida Cell for 15% Equity - Analyst Blog

Novartis ( NVS ) recently entered into an investment and option agreement with Israel-based Gamida Cell, a company which focuses on stem cell expansion technologies and therapeutic products. As per the terms of the agreement, Novartis will invest ...
 Zacks.com1 day ago Novartis Takes Stake In Gamida Cell With Option To Acquire  Bidness Etc2 days ago Novartis to invest heavily in Gamida Cell  Globes4 days ago Deal Is Back On: Novartis AG To Invest Heavily In Gamida Cell Ltd. Before Acquisition  BioSpace3 days ago

Novartis to buy stake in Gamida Cell

Israel's Gamida Cell Ltd., a developer of stem cell-based medicines, said Switzerland's Novartis AG has agreed to pay $35 million for a 15% stake and taken an option to buy its remaining equity for $165 million. The total cost of the buyout ...
 TheDeal.com2 days ago Novartis establishes stake in Israeli stem cell firm  Seeking Alpha2 days ago

Why Novartis (NVS) Stock Is Gaining Today

08/19/14 - 08:28 AM EDT NEW YORK ( TheStreet ) -- Shares of Novartis ( NVS ) are up 0.88% to $88.27 in pre-market trade after it was reported that the Swissdrugmmaker agreed to take a 15% stake in Gamida Cell , an Israeli developer of stem cell ...
 TheStreet.com2 days ago Potential Novartis AG (NVS) Trade Has 3.09% Downside Protection  Individual.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less